U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Blood, Vaccines and Other Biologics
  5. Cellular, Tissue, and Gene Therapies Advisory Committee
  6. Roster of the Cellular, Tissue and Gene Therapies Advisory Committee
  1. Cellular, Tissue, and Gene Therapies Advisory Committee

Roster of the Cellular, Tissue and Gene Therapies Advisory Committee

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies: 0

Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Tabassum (Taby) Ahsan, Ph.D. ****
Expertise: Biomedical Engineering
Term: 05/17/2021-03/31/2026
Vice President Cell and Gene Therapy Operations
City of Hope 
Duarte, CA  91010
Christopher K. Breuer, M.D.
Expertise: General Surgery and Pediatric Surgery
Term: 06/07/2018-03/31/2026
Director of Tissue Engineering Program and Surgical Research
Director, Center for Regenerative Medicine
Nationwide Children’s Hospital  
Columbus, OH 43215
Anne-Virginie Eggimann, M.Sc. *
Expertise: Industry Representative
Term: 07/18/2024-03/31/2028
Chief Regulatory Officer
Tessera Therapeutics, Inc.
Somerville, MA 02143
Melissa A. Greenwald, M.D., CAPT USPHS (Ret.) +
Expertise: Alternate Industry Representative
Term: 07/18/2024-03/31/2028
Medical, Scientific, and Regulatory Consultant
MA Greenwald Consulting, LLC
Chicago, IL 60640
Donald B. Kohn, M.D.
Expertise: Gene Therapies for Blood Diseases
Term: 08/23/2022-03/31/2025
Distinguished Professor
Departments of Microbiology, Immunology and Molecular Genetics; Pediatrics; and Molecular and Medical Pharmacology
David Geffen School of Medicine at UCLA
University of California, Los Angeles
Los Angeles, CA 90095
Wendy B. London, Ph.D.
Expertise: Biostatistics, Clinical Trial Design, Oncology
Term: 04/01/2023-03/31/2027
Associate Professor of Pediatrics
Boston Children's Hospital/Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA 02215
Troy Lund, Ph.D., M.D.
Expertise: Gene Therapy, Biomedical Sciences, Stem Cell Biology
Term: 08/30/2024-03/31/2028
Associate Professor 
Associate Director Metabolic Program 
Pediatric Blood and Marrow Transplant Fellowship Director 
Leukodystrophy Center of Excellence 
Division of Pediatric Blood and Marrow Transplantation and Cellular Therapy 
University of Minnesota Medical Center
Minneapolis, MN 55455
Sean J. Morrison, Ph.D.
Expertise: Stem Cell Biology
Term: 06/07/2018-03/31/2026
Director
Children’s Medical Center Research Institute
University of Texas Southwestern Medical Center
Dallas, TX 75390
Kathleen O’Sullivan-Fortin, Esq.**
Expertise: Consumer Representative
Term: 08/23/2022-03/31/2025
Founder, ALD Connect, Inc.
Middleton, MA 01949
Melanie Ott, M.D., Ph.D.
Expertise: Virology and Immunology
Term: 04/01/2022-03/31/2026
Director, Senior Investigator, Gladstone Institute of Virology 
Senior Vice President, Gladstone Institutes
University of California, San Francisco
San Francisco, CA 94158
Nirali N. Shah, M.D., M.H.Sc.
Expertise: Hematology and Oncology 
Term: 02/04/2022-03/31/2026
Head, Hematologic Malignancies Section
Pediatric Oncology Branch
Lasker Clinical Research Scholar
National Cancer Institute
Bethesda, MD 20892
Evan Y. Snyder, M.D., Ph.D.
Expertise: Neurobiology, Cell Biology, Pediatric
Neurology
Term: 08/30/2024-03/31/2028
Director, Center for Stem Cells and Regenerative Medicine 
Professor, Human Genetics Program 
Sanford Burnham Prebys Medical Discovery Institute 
La Jolla, CA 92037
Cynthia J. Tifft, M.D., Ph.D.
Expertise: Gene Therapy, Pediatrics, Lysosomal
Storage Disorders
Term: 08/30/2024-03/31/2028
Deputy Clinical Director and Senior Clinician
Director, Pediatric Undiagnosed Diseases Program
National Human Genome Research Institute 
National Institutes of Health
Bethesda, MD 20892
Gil I. Wolfe, M.D., F.A.A.N.
Expertise: Neurology
Term: 02/04/2022-03/31/2026
SUNY Distinguished Professor
Neurology Chief of Service, Kaleida Health
Dept. of Neurology, Jacobs School of Medicine
and Biomedical Sciences
University at Buffalo/SUNY
Buffalo, NY 14202
Joseph Wu, M.D., Ph.D.
Expertise: Cardiology and Radiology
Term: 11/28/2016-03/31/2025
Director, Stanford Cardiovascular Institute
Professor of Medicine and Radiology
Stanford University
Stanford, CA 94305
* Industry Representative
** Consumer Representative
+ Alternate Industry Representative
**** Chairperson
Designated Federal Officer
Marie DeGregorio
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
Designated Federal Officer
LCDR Cicely Reese, Pharm.D.
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
E-mail: CTGTAC@fda.hhs.gov
Director
Prabhakara Atreya, Ph.D.
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993 
E-mail: CTGTAC@fda.hhs.gov
Committee Management Officer
Joanna Malsch
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993 
E-mail: CTGTAC@fda.hhs.gov
Committee Management Specialist
Tonica Burke, B.S.
Division of Scientific Advisors and Consultants
Center for Biologics Evaluation and Research
Food and Drug Administration
Silver Spring, MD 20993
E-mail: CTGTAC@fda.hhs.gov
 
Back to Top